Edition:
United Kingdom

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

1.90USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$1.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,918
52-wk High
$3.07
52-wk Low
$1.36

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 1.94
Market Cap(Mil.): $36.05
Shares Outstanding(Mil.): 20.48
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.54 -- --
ROI: -25.10 7.52 12.69
ROE: -43.43 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates